Registration Dossier
Registration Dossier
Data platform availability banner - registered substances factsheets
Please be aware that this old REACH registration data factsheet is no longer maintained; it remains frozen as of 19th May 2023.
The new ECHA CHEM database has been released by ECHA, and it now contains all REACH registration data. There are more details on the transition of ECHA's published data to ECHA CHEM here.
Diss Factsheets
Use of this information is subject to copyright laws and may require the permission of the owner of the information, as described in the ECHA Legal Notice.
EC number: 814-835-0 | CAS number: 1310672-91-3
- Life Cycle description
- Uses advised against
- Endpoint summary
- Appearance / physical state / colour
- Melting point / freezing point
- Boiling point
- Density
- Particle size distribution (Granulometry)
- Vapour pressure
- Partition coefficient
- Water solubility
- Solubility in organic solvents / fat solubility
- Surface tension
- Flash point
- Auto flammability
- Flammability
- Explosiveness
- Oxidising properties
- Oxidation reduction potential
- Stability in organic solvents and identity of relevant degradation products
- Storage stability and reactivity towards container material
- Stability: thermal, sunlight, metals
- pH
- Dissociation constant
- Viscosity
- Additional physico-chemical information
- Additional physico-chemical properties of nanomaterials
- Nanomaterial agglomeration / aggregation
- Nanomaterial crystalline phase
- Nanomaterial crystallite and grain size
- Nanomaterial aspect ratio / shape
- Nanomaterial specific surface area
- Nanomaterial Zeta potential
- Nanomaterial surface chemistry
- Nanomaterial dustiness
- Nanomaterial porosity
- Nanomaterial pour density
- Nanomaterial photocatalytic activity
- Nanomaterial radical formation potential
- Nanomaterial catalytic activity
- Endpoint summary
- Stability
- Biodegradation
- Bioaccumulation
- Transport and distribution
- Environmental data
- Additional information on environmental fate and behaviour
- Ecotoxicological Summary
- Aquatic toxicity
- Endpoint summary
- Short-term toxicity to fish
- Long-term toxicity to fish
- Short-term toxicity to aquatic invertebrates
- Long-term toxicity to aquatic invertebrates
- Toxicity to aquatic algae and cyanobacteria
- Toxicity to aquatic plants other than algae
- Toxicity to microorganisms
- Endocrine disrupter testing in aquatic vertebrates – in vivo
- Toxicity to other aquatic organisms
- Sediment toxicity
- Terrestrial toxicity
- Biological effects monitoring
- Biotransformation and kinetics
- Additional ecotoxological information
- Toxicological Summary
- Toxicokinetics, metabolism and distribution
- Acute Toxicity
- Irritation / corrosion
- Sensitisation
- Repeated dose toxicity
- Genetic toxicity
- Carcinogenicity
- Toxicity to reproduction
- Specific investigations
- Exposure related observations in humans
- Toxic effects on livestock and pets
- Additional toxicological data
![](https://echa.europa.eu/o/diss-blank-theme/images/factsheets/A-REACH/factsheet/print_toxicological-information.png)
Endpoint summary
Administrative data
Description of key information
An additional acute toxicity study is not necessary as there is data available from short-term 14-day repeated dose toxicity studies of CD08467 and CD08479 in minipigs and rats, respectively. Repeated dose-administration studies supersede the need of additional single dose acute toxicity testing.
The acute toxicity potential of CD08467 as well as its analogue CD08479 has been investigated in two sub-acute studies (see IUCLID section 7.5.1: Weiler, 2012 and Maury, 2012). CD08467 was administered daily for 2 weeks via oral gavage to minipigs at 300, 600, or 1 200 mg/kg bw/day (the maximal feasible dose due to the limit of formulability of CD08467). No mortality was observed with all 3 doses and slight treatment-related effects were seen only at the highest dose of 1 200 mg/kg. No toxicity was seen at 300 or 600 mg/kg bw/day. In another study, CD08479, the structurally related analogue of CD08467, was administered daily to rats at 420 mg/kg bw/day for 2 weeks, and no toxicity was observed at this dose. Thus, the sub-acute non-toxic dose levels have been demonstrated to be 600 mg/kg bw/day in minipigs for CD08467 and 420 mg/kg bw/day in rats for CD08479.
Based on the available data showing no mortality of both studies, it can be expected that the LD50 of CD08467 by oral route is higher than the maximum (technically feasible) dose of 1 200 mg/kg bw/day in the minipigs (non-rodent toxicity with CD08467) and higher than 420 mg/kg bw/day in the rat (rodent toxicity with CD08479).
In addition, both CD08467 and CD08479 are rapidly converted into salicylic acid and benzoic acid (1 mol CD08467 or CD08479 yields 1 mol salicylic acid and 1 mol benzoic acid), which are known compounds with available acute toxicity data. According to the ECHA’s C&L inventory, benzoic acid is not classified for acute toxicity. Salicylic acid is classified as Acute Tox. 4 (H302) based on a LD50 of 891 mg/kg bw (see registration dossier of salicylic acid). By extrapolating the LD50 of the metabolite salicylic acid (MW = 122.12 g/mol) to CD08467 (MW = 344.32 g/mol), the LD50 for CD08467 would be 2512 mg/kg bw, and thus, no classification is warranted for CD08467 for acute toxicity based on the criteria under CLP Regulation.
Key value for chemical safety assessment
Acute toxicity: via oral route
Link to relevant study records
- Endpoint:
- acute toxicity: oral
- Data waiving:
- study scientifically not necessary / other information available
- Justification for data waiving:
- other:
- Justification for type of information:
- An acute toxicity study is not necessary as there is data available from short-term 14-day repeated dose toxicity studies of CD08467 and CD08479 in minipigs and rats, respectively. Repeated dose-administration studies supersede the need of additional single dose acute toxicity testing.
The acute toxicity potential of CD08467 as well as its analogue CD08479 has been investigated in a few short-term duration studies (see IUCLID section 7.5.1: Weiler, 2012 and Maury, 2012). CD08467 was administered daily for 2 weeks via oral gavage to Göttingen® minipigs at 300, 600, or 1 200 mg/kg bw/day (the maximal feasible dose due to the limit of formulability of CD08467). No mortality was observed with all 3 doses and slight treatment-related effects were seen only at the highest dose of 1 200 mg/kg. No toxicity was seen at 300 or 600 mg/kg bw/day. In another study, CD08479, the structurally related analogue of CD08467, was administered daily to rats at 420 mg/kg bw/day for 2 weeks, and no toxicity was observed at this dose. Thus, the acute non-toxic dose levels have been demonstrated to be 600 mg/kg bw/day in minipigs for CD08467 and 420 mg/kg bw/day in rats for CD08479.
Based on the available data showing no mortality of both studies, it can be expected that the LD50 of CD08467 by oral route is higher than the maximal feasible dose of 1 200 mg/kg bw/day in the minipigs (non-rodent toxicity with CD08467) or higher than 420 mg/kg bw/day in the rat (rodent toxicity with CD08479).
In addition, both CD08467 and CD08479 are rapidly converted into salicylic acid and benzoic acid (1 mol CD08467 or CD08479 yields 1 mol salicylic acid and 1 mol benzoic acid), which are known compounds with available acute toxicity data. According to the ECHA’s C&L inventory, benzoic acid is not classified for acute toxicity, but salicylic acid is classified as Acute Tox. 4 (H302) based on a LD50 of 891 mg/kg bw (see registration dossier of salicylic acid). By extrapolating the LD50 of salicylic acid (MW = 122.12 g/mol) to CD08467 (MW = 344.32 g/mol), the LD50 for CD08467 would be 2512 mg/kg bw, and thus, no classification is warranted for CD08467 for acute toxicity based on the criteria under CLP Regulation.
For further details see attached justification “CD08467 Acute toxicity waiver 7844907273609635930.pdf” - Reason / purpose for cross-reference:
- data waiving: supporting information
- Reason / purpose for cross-reference:
- data waiving: supporting information
Reference
Endpoint conclusion
- Endpoint conclusion:
- no adverse effect observed
- Quality of whole database:
- 2-week oral gavage study in Göttingen minipigs
Acute toxicity: via inhalation route
Endpoint conclusion
- Endpoint conclusion:
- no study available
Acute toxicity: via dermal route
Endpoint conclusion
- Endpoint conclusion:
- no study available
Additional information
Justification for classification or non-classification
Based on the available data, CD08467 does not warrant classification for acute toxicity.
Information on Registered Substances comes from registration dossiers which have been assigned a registration number. The assignment of a registration number does however not guarantee that the information in the dossier is correct or that the dossier is compliant with Regulation (EC) No 1907/2006 (the REACH Regulation). This information has not been reviewed or verified by the Agency or any other authority. The content is subject to change without prior notice.
Reproduction or further distribution of this information may be subject to copyright protection. Use of the information without obtaining the permission from the owner(s) of the respective information might violate the rights of the owner.
![ECHA](/o/diss-blank-theme/images/factsheets/A-REACH/factsheet/echa_logo.png)